Furthermore, our findings show that melatonin deregulates Smad7 expression to suppress TGFβ/Smad-mediated increase in CCL20 transcript levels and CCL20-induced EMT occurrence, suggesting potential anti-EMT therapeutic strategy of melatonin to overcome malignant transformation in gliomas. This evidence concerns the gene SMAD7 and central nervous system cancer.